[Neonatal immune system changes caused by phototherapy]

Insights

Phototherapy for neonatal hyperbilirubinemia may temporarily impair immune cell function, indicated by reduced phagocyte response. This could potentially complicate infections in newborns undergoing treatment.

Area of Science:

  • Neonatal immunology
  • Phototherapy research
  • Cellular function studies

Context:

  • Phototherapy is a common treatment for neonatal hyperbilirubinemia.
  • Potential adverse effects of phototherapy on neonates include behavioral changes and increased infection risk.
  • Electromagnetic radiation from phototherapy devices may impact cellular functions.

Purpose:

  • To investigate the effects of phototherapy on the immune system of healthy neonates with hyperbilirubinemia.
  • To assess changes in immune cell counts and functions before and after phototherapy.
  • To evaluate the impact of phototherapy on the chemiluminescent response of leukocytes.

Summary:

  • Phototherapy treatment for neonatal hyperbilirubinemia was examined in healthy neonates.
  • Measurements included physical exams, white blood cell counts, lymphocyte markers, and leukocyte chemiluminescence.
  • Results indicated an increase in white blood cells but a delayed and weakened chemiluminescent response in phagocytes post-phototherapy.

Impact:

  • Phototherapy may temporarily decrease the functional capacity of phagocytes, potentially complicating infections like bacteremia.
  • Findings suggest a transient immunosuppressive effect of phototherapy on neonatal immune cells.
  • Understanding these temporary immune alterations is crucial for managing neonatal hyperbilirubinemia and associated risks.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...